trending Market Intelligence /marketintelligence/en/news-insights/trending/YzNQ5BvxnIh0JPe2gxeILQ2 content esgSubNav
In This List

Merrimack appoints president, CEO

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes

Blog

Investment Banking Essentials Newsletter April Edition - 2022


Merrimack appoints president, CEO

Merrimack Pharmaceuticals Inc. appointed Richard Peters as its president and CEO, effective Feb. 6.

Peters will also be appointed a director on the same day. The appointee currently serves as senior vice president and head of global rare diseases at Sanofi Genzyme, a Sanofi subsidiary.

Merrimack's interim president and CEO, Gary Crocker, will continue to serve as the chairman of the board.